These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 36151259)
1. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients. Hua L; Lei P; Hu Y Sci Rep; 2022 Sep; 12(1):15893. PubMed ID: 36151259 [TBL] [Abstract][Full Text] [Related]
2. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma. Lei T; Qian H; Lei P; Hu Y Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma. Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882 [TBL] [Abstract][Full Text] [Related]
4. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
5. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature. Chen W; Lin W; Wu L; Xu A; Liu C; Huang P Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523 [No Abstract] [Full Text] [Related]
6. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction. Zhu J; Yuan J; Arya S; Du Z; Liu X; Jia J Front Immunol; 2023; 14():1265098. PubMed ID: 38169731 [TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma. Cheng L; Xiong W; Li S; Wang G; Zhou J; Li H J Gene Med; 2023 Dec; 25(12):e3563. PubMed ID: 37421290 [TBL] [Abstract][Full Text] [Related]
8. Identification of TNFRSF1A as a potential biomarker for osteosarcoma. Zhang Y; Liu K; Wang J Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759 [TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma. Peng YL; Wang LX; Li MY; Liu LP; Li RS PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis. Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H Front Immunol; 2022; 13():997765. PubMed ID: 36275664 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes. Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes. Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L Front Genet; 2022; 13():919638. PubMed ID: 35783277 [No Abstract] [Full Text] [Related]
13. Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer. Yang Z; Li J; Tang Y; Zou L Reprod Sci; 2023 Jun; 30(6):2003-2015. PubMed ID: 36576713 [TBL] [Abstract][Full Text] [Related]
14. A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma. Zhao S; Wang T; Huang F; Zhao Q; Gong D; Liu J; Yi C; Liang S; Bian E; Tian D; Jing J Biochem Genet; 2024 Apr; 62(2):831-852. PubMed ID: 37460861 [TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis. Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X Front Immunol; 2022; 13():1085038. PubMed ID: 36618366 [TBL] [Abstract][Full Text] [Related]
16. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. Xie Y; Xu Z; Mei X; Shi W Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905 [TBL] [Abstract][Full Text] [Related]
17. Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme. Li Z; Jin Y; Que T; Zhang XA; Yi G; Zheng H; Yuan X; Wang X; Xu H; Nan J; Chen C; Wu Y; Huang G Curr Med Chem; 2024; 31(33):5417-5431. PubMed ID: 37539935 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of copper-metabolism-related genes about prognosis and immune microenvironment in osteosarcoma. Lin Z; He Y; Wu Z; Yuan Y; Li X; Luo W Sci Rep; 2023 Sep; 13(1):15059. PubMed ID: 37700003 [TBL] [Abstract][Full Text] [Related]
19. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma. Hong X; Fu R PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294 [TBL] [Abstract][Full Text] [Related]
20. Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma. Zhang Q; Zhu Z; Guan J; Zheng C Front Oncol; 2022; 12():904614. PubMed ID: 35814424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]